NCT04649281

Brief Summary

Pain is one of the most common causes of healthcare contact and long-term sick leave, with negative consequences on physical and mental health. Poor sleep is common in chronic pain patients. Epidemiological studies indicate that 5-7% of patients with chronic pain are treated regularly with strong opioids. Negative side effects of pain modulating drugs on sleep quality have been reported, which may have negative influence on overall disease management in chronic pain patients. However, to date there are conflicting results regarding the effects of opioids on sleep, since the pain relieving effect of opioids seem to affect sleep positively. There is data suggesting that physical activity has positive effects on both pain perception and sleep quality (and duration). The aim of the study is to explore insomnia and characteristics of sleep in patients with chronic pain and the relationship with physical activity level and opioid use.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable chronic-pain

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 12, 2020

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

October 28, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 2, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

December 2, 2020

Status Verified

November 1, 2020

Enrollment Period

1.2 years

First QC Date

October 28, 2020

Last Update Submit

November 30, 2020

Conditions

Keywords

AccelerometryMental fatigueSelf-Efficacy

Outcome Measures

Primary Outcomes (5)

  • Sleep

    Sleep duration in minutes assessed by accelerometry

    Daily assessment during one week

  • Sleep

    Sleep timing, i.e. sleep onset and wake time assessed by accelerometry

    Daily assessment during one week

  • Physical activity

    Minutes of physical activity per week at moderate and vigorous intensity physical activity (MVPA), minutes of sedentary behaviour (SED) assessed by accelerometry

    Daily assessment during one week

  • Opioid consumption

    Opioid consumption in morphine equivalent doses

    Opioid consumption at study enrollment

  • Pain intensity

    Pain intensity according to Numeric Rating Scale (NRS), score from 0 to 10, where 0 is described as "no pain" and 10 as "worst pain imaginable"

    Daily assessment during one week

Secondary Outcomes (7)

  • Insomnia Severity

    Insomnia severity at enrollment

  • Sleep quality

    Sleep quality at study enrollment

  • Daytime sleepiness

    Daytime sleepiness at study enrollment

  • Self-assessed physical activity

    Self-assessed physical activity at study enrollment

  • Self-efficacy for exercise scale

    Self-efficacy for exercise at study enrollment

  • +2 more secondary outcomes

Other Outcomes (2)

  • Neurofilament light

    Neurofilament light at study enrollment

  • 25-hydroxyvitamin D

    25-hydroxyvitamin D at study enrollment

Study Arms (1)

Accelerometry

OTHER

Recording of sleep and physical activity by accelerometry during one week.

Device: Accelerometry

Interventions

Recording of sleep and physical activity by accelerometry during one week.

Accelerometry

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic pain (i.e. pain \> 3 months)
  • Planned follow up at the Pain Centre
  • Age ≥18 years
  • Consents to participation in the study

You may not qualify if:

  • Inadequate knowledge of the Swedish language
  • Alcohol or substance abuse
  • Severe untreated psychiatric disorders including psychiatric disease and/or psychological conditions which are the primary determinant to the patient's pain condition
  • Malignant disease with short expected survival

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pain Centre, Department of Anaesthesiology and Intensive Care Medicine Östra, Sahlgrenska University Hospital, Region Västra Götaland

Gothenburg, Sweden

RECRUITING

MeSH Terms

Conditions

Chronic PainSleep Initiation and Maintenance DisordersMotor ActivitySleep Wake DisordersMental Fatigue

Interventions

Accelerometry

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasNervous System DiseasesMental DisordersBehaviorFatigueBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Paulin Andréll, MD, PhD

    Sahlgrenska University Hospital, Region Västra Götaland; Göteborg University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Paulin Andréll, MD, PhD

CONTACT

Martin Olsson, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 28, 2020

First Posted

December 2, 2020

Study Start

October 12, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

December 2, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations